Commonwealth Equity Services, LLC Argenx Se Transaction History
Commonwealth Equity Services, LLC
- $75.7 Billion
- Q2 2025
A detailed history of Commonwealth Equity Services, LLC transactions in Argenx Se stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 1,067 shares of ARGX stock, worth $844,626. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,067
Previous 649
64.41%
Holding current value
$844,626
Previous $384,000
53.13%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
491Shares Held
28.3MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.94 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$2.21 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$2.03 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.54 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$930 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $43.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...